# FDA Inspection 1206061 - Konrad Rejdak, M.D., Ph.D. - May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/konrad-rejdak-md-phd/11a37c52-0af4-4ca9-ae20-1862fc12e96e
Source feed: FDA_Inspections

> FDA Inspection 1206061 for Konrad Rejdak, M.D., Ph.D. on May 19, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206061
- Company Name: Konrad Rejdak, M.D., Ph.D.
- Inspection Date: 2023-05-19
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/konrad-rejdak-md-phd/c259d78e-b215-4f03-980e-b22dd82a2f27

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d